Immersive Virtual Reality–Assisted Therapy for Distressing Voices in Psychosis: Qualitative Study of Participants’ and Therapists’ Experiences in the Challenge Trial
JMIR Serious Games · 01.12.2025 · 13 · e77920-e77920
DOI: 10.2196/77920 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift JMIR Serious Games, online erschienen am 01.12.2025. Verfasst von Mads Juul Christensen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Psychiatry, Aalborg University Hospital, North Denmark Region, Brandevej 5, Aalborg, 9220, Denmark, 0045 20551002. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Immersive virtual reality–assisted therapy (VRT) is a relational therapy for distressing voices in psychosis. Like AVATAR therapy (AT), VRT centers on therapist-facilitated dialogues with a digital avatar representing a voice. Unlike AT, VRT uses immersive virtual reality (VR). While participant experiences of AT have been explored, therapist perspectives remain unexamined, and for VRT, neither participant nor therapist experiences have been studied. Understanding these perspectives is essential to inform optimization of therapy, future research, and implementation.
Objective
The objective of this qualitative study was to explore both trial participants’ and therapists’ experience of VRT in the Challenge trial.
Methods
Semistructured interviews were conducted with 10 trial participants and 8 therapists across the 3 Challenge trial sites. Trial participants were purposively sampled to ensure site representation and variation in voice-hearing duration. Individual interviews were conducted with trial participants, while therapists participated in site-based groups with 2‐3 in each. Interviews were audio-recorded, transcribed, and subjected to reflexive thematic analysis from a critical realist position. Coding and theme development were inductive. People with lived experience were invited to an initial focus group for topic guide development and a later theme validation workshop. Reporting followed the Standards of Reporting Qualitative Research (SRQR).
Results
A total of five overarching themes were generated: (1) using technology to meet the voice, (2) a different approach to voice-hearing and treatment, (3) on a tight schedule, (4) a toolbox for transformation, and (5) a price to pay. Trial participants and therapists generally found VRT acceptable, appropriate, and feasible. Highlights included the acknowledging approach to the voice(s), facilitation of engagement with the voice(s), and opportunity to share the otherwise private experience of voice-hearing. Externalizing and embodying the voice(s) in VR-supported avatar role-plays was seen as a key affordance. Positive outcomes included increased trial participant empowerment and self-worth, enabling or improving voice dialogue, new understanding of voice intentions, and changes in voice frequency or content. Challenges included instances of participant anxiety, exhaustion, or suboptimal sense of (voice) presence; adverse voice reactions; technological malfunctions and limitations to avatar design; measurement insensitivity; tensions between assertiveness and compassion; difficulties with reproducing negative voice content; and the demanding nature of the therapy and the nontraditional skills required of therapists.
Conclusions
The study provided comprehensive insights into trial participants’ and therapists’ experiences of VRT in the Challenge trial. Findings share several similarities with qualitative research on other relational therapies for distressing voices and highlight VRT’s potential for positive change. Key considerations for future research and implementation include monitoring anxiety and voice reactions, ensuring operational reliability of hardware and software, and addressing the additional effort required by therapists, which may be unsustainable in routine practice. As a demanding intervention, the successful implementation of VRT will require adequate training, supervision, and structural support.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Psychiatry, Aalborg University Hospital, North Denmark Region, Brandevej 5, Aalborg, 9220, Denmark, 0045 20551002.
- Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
- Unit for Psychiatric Research, Psychiatry, Aalborg University Hospital, North Denmark Region, Aalborg, Denmark.
- Department of Health Economics, University of Southern Denmark, Odense, Denmark.
- Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia.
- Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia.
Zitieren
APA
Christensen, M. J., Rydborg, M. P., Jørgensen, R., Nielsen, C. D., Mainz, J., Bell, I. H., Thomas, N., Smith, L. C., Mariegaard, L. S., Ward, T., Nordentoft, M., Glenthøj, L. B., & Vernal, D. L. (2025). Immersive Virtual Reality–Assisted Therapy for Distressing Voices in Psychosis: Qualitative Study of Participants’ and Therapists’ Experiences in the Challenge Trial. JMIR Serious Games, 13, e77920-e77920. https://doi.org/10.2196/77920
Vancouver
Christensen MJ, Rydborg MP, Jørgensen R, Nielsen CD, Mainz J, Bell IH, et al. Immersive Virtual Reality–Assisted Therapy for Distressing Voices in Psychosis: Qualitative Study of Participants’ and Therapists’ Experiences in the Challenge Trial. JMIR Serious Games. 2025;13:e77920-e77920. doi:10.2196/77920
BibTeX
@article{Christensen2025,
author = {Christensen, Mads Juul and Rydborg, Matilde Poulsen and Jørgensen, Rikke and Nielsen, Cecilie Dueholm and Mainz, Jan and Bell, Imogen H and Thomas, Neil and Smith, Lisa Charlotte and Mariegaard, Lise Sandvig and Ward, Thomas and Nordentoft, Merete and Glenthøj, Louise Birkedal and Vernal, Ditte Lammers},
title = {Immersive Virtual Reality–Assisted Therapy for Distressing Voices in Psychosis: Qualitative Study of Participants’ and Therapists’ Experiences in the Challenge Trial},
journal = {JMIR Serious Games},
year = {2025},
volume = {13},
pages = {e77920--e77920},
doi = {10.2196/77920}
}
EUVIMED